πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11382989

Engineered microbial population

The Board of Regents of the University of Texas System Β· Granted Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11377491

Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and

The Board of Regents of the University of Texas System Β· Granted Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11376324

Sting activating nanovaccine for immunotherapy

The Board of Regents of the University of Texas System Β· Granted Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11369716

Reparative cell isolation and delivery

The Board of Regents of the University of Texas System Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11370786

GLS1 inhibitors for treating disease

The Board of Regents of the University of Texas System Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11370757

Photocleavable nitroindoline-based crosslinkers

The Board of Regents of the University of Texas System Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11365189

Heterocyclic inhibitors of tyrosine kinase

The Board of Regents of the University of Texas System Β· Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11365250

Compositions and methods for cancer therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11365413

Inhibition of poly(A) binding protein and the treatment of pain

The Board of Regents of the University of Texas System Β· Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11364197

Compositions and methods of making brittle-matrix particles through blister pack freezing

The Board of Regents of the University of Texas System Β· Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11365183

Eicosanoid derivatives

The Board of Regents of the University of Texas System Β· Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11358991

Heme sequesting peptides and uses therefor

The Board of Regents of the University of Texas System Β· Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11344577

Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

The Board of Regents of the University of Texas System Β· Granted Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11344578

Immune cells expressing engineered antigen receptors

The Board of Regents of the University of Texas System Β· Granted Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11345659

Pipecolic esters for inhibition of the proteasome

The Board of Regents of the University of Texas System Β· Granted Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11332483

Naphthoquinone containing gold carbene complexes and methods of uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11331333

Treatment of aberrant fibroblast proliferation

The Board of Regents of the University of Texas System Β· Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11325898

Small molecule inducers of autophagy

The Board of Regents of the University of Texas System Β· Granted Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11318186

Use of FGF21 in methods of increasing exocrine pancreatic secretion

The Board of Regents of the University of Texas System Β· Granted Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11313868

Methods of detecting anti-folic acid antibodies and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11304916

Methods and compositions for the treatment of Shiga Toxicosis

The Board of Regents of the University of Texas System Β· Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11304911

Compositions and methods for organ specific delivery of nucleic acids

The Board of Regents of the University of Texas System Β· Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11299512

Cyclic di-nucleotide compounds and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11293024

Antisense antibacterial compounds and methods

The Board of Regents of the University of Texas System Β· Granted Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted